Navigation Links
PharmAthene Appoints Jeffrey W. Runge, M.D. to the Company's Board of Directors
Date:12/21/2009

ANNAPOLIS, Md., Dec. 21 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, today announced the appointment of Jeffrey W. Runge, M.D. to PharmAthene's Board of Directors, increasing the Board to eight members.

Dr. Runge is a Principal at The Chertoff Group, a firm providing advisory services in business risk management, homeland security and homeland defense. He is also the President and founder of Biologue, Inc., which provides consulting in biodefense, medical preparedness and injury prevention and control. From 2001 through August of 2008, Dr. Runge served in the Bush administration, first as the head of the National Highway Traffic Safety Administration, confirmed by the Senate in August 2001. In September 2005, he became the Department of Homeland Security's first Chief Medical Officer and founded the DHS Office of Health Affairs in 2007. He was confirmed by the Senate as DHS' first Assistant Secretary for Health Affairs in December of 2007. Dr. Runge also served as Acting DHS Undersecretary for Science and Technology from February through August 2006. In his role at DHS, Dr. Runge oversaw the operations of the department's biodefense activities, medical preparedness and workforce health protection, including managing DHS' role in Project BioShield, working with the various federal departments on medical countermeasure assurance.

Prior to joining DHS, Dr. Runge was Assistant Chairman of the Department of Emergency Medicine at the Carolinas Medical Center in Charlotte, NC, from 1984 through 2001.

Dr. Runge earned his medical degree from the Medical University of South Carolina and his undergraduate degree from the University of the South.

"We are delighted to welcome Dr. Runge to t
'/>"/>

SOURCE PharmAthene, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. PharmAthene Announces Updated Time for Conference Call to Review BARDA rPA Decision
2. PharmAthene Reports Third Quarter 2009 Financial and Operational Results
3. PharmAthene Executives Featured in Anthrax Pathogen Training Video for U.S. Department of Homeland Security
4. PharmAthene Presents Data for Valortim(R) Anthrax Anti-Toxin and Third Generation rPA Anthrax Vaccine Programs at the Bacillus - ACT 2009 Conference
5. PharmAthene to Present at the Rodman and Renshaw Annual Global Investment Conference September 10, 2009
6. PharmAthene Reports Second Quarter 2009 Financial and Operational Results
7. PharmAthene to Host Second Quarter 2009 Conference Call and Webcast on Thursday, August 13, 2009
8. PharmAthene, Inc. Closes on $19.3 Million Private Placement of Convertible Notes and Common Stock Warrants
9. PharmAthenes 2nd Generation rPA Anthrax Vaccine, SparVax(TM), Completes FDA Regulatory Strategy Review
10. PharmAthene Reports First Quarter 2009 Financial and Operational Results
11. PharmAthene Announces New Date for First Quarter 2009 Conference Call and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... Calif. , March 30, 2015  NuGene ... its subsidiary corporation, NuGene BioPharma, Inc. has added ... Dr. Guan is an internationally recognized ... finishing his college education at Peking University, ... Ph.D. degree from the University of North Carolina, ...
(Date:3/30/2015)... -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI ), a ... of innovative therapeutics addressing cancer and other unmet medical ... on China , announced today that ... the Company,s application to conduct a Phase 2 global ... for its proprietary drug candidate ENMD-2076.  ...
(Date:3/30/2015)... 30, 2015  Spherix Incorporated (Nasdaq: SPEX ... fostering and monetization of intellectual property, today provided ... 3:13-cv-03494-M and  Spherix v. Uniden , Case No. ... for the Northern District of Texas ... v. Verizon, Case No. 1:14-cv-00721-GBL-TCB, in the ...
(Date:3/30/2015)... PARK, N.J. , March 30, 2015 /PRNewswire/ ... (PAMORA) under development by Shionogi & Co., Ltd., ... phase III study (COMPOSE I) for the treatment ... chronic non-cancer pain receiving opioid therapy. Study results ... daily) statistically significantly improved the frequency of spontaneous ...
Breaking Biology Technology:UCI Professor Zhibin Guan Joins NuGene Advisory Board 2UCI Professor Zhibin Guan Joins NuGene Advisory Board 3CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 2CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 3CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 4CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 5Spherix Provides Update on Litigation vs. VTech, Uniden and Verizon 2Spherix Provides Update on Litigation vs. VTech, Uniden and Verizon 3Shionogi & Co., Ltd. Announces That Naldemedine Meets Primary Endpoint In A Phase 3 Study For The Treatment Of Opioid-Induced Constipation 2Shionogi & Co., Ltd. Announces That Naldemedine Meets Primary Endpoint In A Phase 3 Study For The Treatment Of Opioid-Induced Constipation 3
... Reportlinker.com announces that a new market research report is available in its catalogue: , ... Vitro Diagnostics Market Outlook to 2016 , , , ... , , China In Vitro Diagnostics Market Outlook ... Summary , , , ...
... , July 19 Reportlinker.com announces that a new market research report is available in ... Stem Cells Market And Applications. 2009-2015 , ... http://www.reportlinker.com/p0239912/Stem-Cells-Market-And-Applications-2009-2015.html , , , ... , The ,Stem Cells Market and ...
... Tecnalia Construction Unit, within the framework of its commitment ... cements that enable cutting direct CO2 emissions to the ... new ecological cement, as well as the techniques for ... the obtention of two patents, whose ownership is shared ...
Cached Biology Technology:Reportlinker Adds China In Vitro Diagnostics Market Outlook to 2016 2Reportlinker Adds China In Vitro Diagnostics Market Outlook to 2016 3Reportlinker Adds China In Vitro Diagnostics Market Outlook to 2016 4Reportlinker Adds China In Vitro Diagnostics Market Outlook to 2016 5Reportlinker Adds China In Vitro Diagnostics Market Outlook to 2016 6Reportlinker Adds China In Vitro Diagnostics Market Outlook to 2016 7Reportlinker Adds China In Vitro Diagnostics Market Outlook to 2016 8Reportlinker Adds China In Vitro Diagnostics Market Outlook to 2016 9Reportlinker Adds China In Vitro Diagnostics Market Outlook to 2016 10Reportlinker Adds China In Vitro Diagnostics Market Outlook to 2016 11Reportlinker Adds China In Vitro Diagnostics Market Outlook to 2016 12Reportlinker Adds China In Vitro Diagnostics Market Outlook to 2016 13Reportlinker Adds China In Vitro Diagnostics Market Outlook to 2016 14Reportlinker Adds China In Vitro Diagnostics Market Outlook to 2016 15Reportlinker Adds China In Vitro Diagnostics Market Outlook to 2016 16Reportlinker Adds China In Vitro Diagnostics Market Outlook to 2016 17Reportlinker Adds China In Vitro Diagnostics Market Outlook to 2016 18Reportlinker Adds China In Vitro Diagnostics Market Outlook to 2016 19Reportlinker Adds China In Vitro Diagnostics Market Outlook to 2016 20Reportlinker Adds China In Vitro Diagnostics Market Outlook to 2016 21Reportlinker Adds China In Vitro Diagnostics Market Outlook to 2016 22Reportlinker Adds China In Vitro Diagnostics Market Outlook to 2016 23Reportlinker Adds China In Vitro Diagnostics Market Outlook to 2016 24Reportlinker Adds China In Vitro Diagnostics Market Outlook to 2016 25Reportlinker Adds China In Vitro Diagnostics Market Outlook to 2016 26Reportlinker Adds Stem Cells Market And Applications. 2009-2015 2Reportlinker Adds Stem Cells Market And Applications. 2009-2015 3Reportlinker Adds Stem Cells Market And Applications. 2009-2015 4Reportlinker Adds Stem Cells Market And Applications. 2009-2015 5Reportlinker Adds Stem Cells Market And Applications. 2009-2015 6Reportlinker Adds Stem Cells Market And Applications. 2009-2015 7Reportlinker Adds Stem Cells Market And Applications. 2009-2015 8Reportlinker Adds Stem Cells Market And Applications. 2009-2015 9Reportlinker Adds Stem Cells Market And Applications. 2009-2015 10Reportlinker Adds Stem Cells Market And Applications. 2009-2015 11
(Date:3/11/2015)... Mar. 11, 2015 Research and Markets ... "Access Control Market by Product, Application & By ... report to their offering. , This report ... reach $10.4 billion by 2020, with an estimated CAGR ... covers the products types such as contact cards & ...
(Date:3/10/2015)... Conn. , March 10, 2015  NXT-ID, ... ("NXT-ID" or the "Company"), a biometric authentication company ... the company,s Wocket™ smart wallet has been named ... by Rethink Modern. Rethink Modern ( ... and innovative items for your home and lifestyle that have ...
(Date:3/2/2015)... 2, 2015  Businesses have a new option ... Tharon Rankins Enterprises has announced the launch of ... way for businesses to protect their customers, personal ... Beconux is a biometric transaction processing ... similarly to an ATM machine, the new system ...
Breaking Biology News(10 mins):Global Access Control (Cards & Readers, Biometrics, Controllers, Management Software) Market 2015-2020 - Analysis of the $10 Billion Market 2NXT-ID's Wocket Smart Wallet Named Number One Best Tech Gift for 2015 by Rethink Modern 2NXT-ID's Wocket Smart Wallet Named Number One Best Tech Gift for 2015 by Rethink Modern 3NXT-ID's Wocket Smart Wallet Named Number One Best Tech Gift for 2015 by Rethink Modern 4Personal Data Protection Company Launches New Product 2
... WASHINGTON, Aug. 14, 2012-- To warn of chemical attacks ... if even trace levels of potentially deadly chemicalssuch as ... present. U.S. Army researchers have developed a new chemical ... of agents, in real time. A paper describing the ...
... University of Leicester is establishing a new forensic science Institute ... The Alec Jeffreys Forensic Science Institute is a new ... help police forces with some of the requests handled by ... aims to be a leader, innovator and agenda setter in ...
... People for the Ethical Treatment of Animals (PETA) ... charged that the National Toxicology Program Interagency Center ... Interagency Coordinating Committee on the Validation of Alternative ... Congressional mandate to facilitate the uptake of nonanimal ...
Cached Biology News:Hearing the telltale sounds of dangerous chemicals 2Hearing the telltale sounds of dangerous chemicals 3New forensic institute at the University of Leicester will help police forces solve 'unusual crimes' 2PETA, PCRM address ICCVAM 5-year plan 2
... RC10 series of vacuum concentrators/centrifugal evaporators offers ... allied to rapid and safe concentration of ... combined with oil-free or high vacuum pumps, ... wide selection of rotors (eliminating sample loss ...
For absolute protein quantification. 4 peptides in 5 vials x 2 nmol per peptide...
For relative and/or absolute quantification with standard accuracy requirements using MS or NMR instruments...
Carrier Serum...
Biology Products: